• Home>
  • Stocks>
  • Jenburkt Pharmaceuticals Ltd Share Price
Jenburkt Pharmaceuticals Ltd share price logo

Jenburkt Pharmaceuticals Ltd Share Price (524731)

Check the latest share price of Jenburkt Pharmaceuticals Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹1334.351.14%

as on 04:01PM, 16 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Jenburkt Pharmaceuticals Ltd Stock Performance

Get live Jenburkt Pharmaceuticals Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹1,302
    Day's Price Range
    ₹1,344.9
  • 52 Week's Low

    52 Week's High

    ₹815.8
    52-Week Price Range
    ₹1,375
1 Month Return+ 21.46 %
3 Month Return+ 39.19 %
1 Year Return+ 56.86 %
3 Year Return+ 159.46 %
5 Year Return+ 254.62 %
Previous Close₹1,319.35
Open₹1,324.10
Volume1,431.00
Upper Circuit₹1,583.20
Lower Circuit₹1,055.50

Jenburkt Pharmaceuticals Ltd Fundamentals & Key Indicators

Check Jenburkt Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹582.27 Cr

Return on Equity (ROE)

19.44

PE Ratio (TTM)

0

Return on capital employed (ROCE)

25.67

Beta (LTM)

1.02

P/B Ratio

2.1

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

8.38

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Jenburkt Pharmaceuticals Ltd?

Investing in Jenburkt Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Jenburkt Pharmaceuticals Ltd or 524731 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Jenburkt Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Jenburkt Pharmaceuticals Ltd with just a few clicks!

Jenburkt Pharmaceuticals Ltd Stock's Interest Amongst Investors

160%

Period Jun 17, 2025 to May 18, 2025. Change in 30 Days vs previous period

Search interest for Jenburkt Pharmaceuticals Ltd Stock has increased by 160% in the last 30 days, reflecting an upward trend in search activity.

Jenburkt Pharmaceuticals Ltd Financial Results

Get the annual and quarterly financial summary of Jenburkt Pharmaceuticals Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

39 (0%)33 (16%)41 (27%)37 (10%)41 (11%)
Net Income

(in ₹ Cr)

8 (0%)7 (6%)10 (29%)7 (32%)9 (31%)
Net Profit Margin20.29% (0%)22.80% (12%)23.29% (2%)17.65% (24%)20.80% (18%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

122 (0%)144 (18%)143 (1%)167 (17%)
Total Liabilities

(in ₹ Cr)

24 (0%)26 (12%)21 (22%)22 (6%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

15 (0%)19 (29%)9 (52%)17 (84%)8 (52%)

Jenburkt Pharmaceuticals Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Jenburkt Pharmaceuticals Ltd.

  • Jenburkt Pharmaceuticals Ltd Earnings Results

    Jenburkt Pharmaceuticals Ltd’s net profit jumped 8.38% since last year same period to ₹8.54Cr in the Q4 2024-2025. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 31.18% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Jenburkt Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹15.30 - translating a dividend yield of 1.15%.

    Read More about Dividends

Jenburkt Pharmaceuticals Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Jenburkt Pharmaceuticals Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
46.68%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
53.2%
0.00
Others
0.12%
0.00

Jenburkt Pharmaceuticals Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Jenburkt Pharmaceuticals Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA582.2750.92%0.5125141
NA505.7311.01%0.6612379
BUY16,926.47623.64%0.543001,558
SELL2,589.406.01%0.67971,817
NA66.79104.9%0.53537

Insights on Jenburkt Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Jenburkt Pharma stock has moved up by 21.5%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Jenburkt Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, Jenburkt Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 53.20% of holdings in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 46.69% to 46.68% in Mar 2025 quarter

About Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd. is a well-established healthcare and pharmaceutical venture, formed by the Bhuta family in 1985. By being listed on the Bombay Stock Exchange, Jenburkt is a public limited company that specializes in manufacturing and marketing high quality pharmaceutical formulations and healthcare products. Headquartered in Mumbai, Jenburkt runs all its operations from the same location.

Founders of the company, the Bhuta family, help maintain the core values of Jenburkt, as over 35 years of experience in the pharmaceutical industry ensures that its products meet the highest standards of quality and efficiency. With a stellar history and experience in the field, Jenburkt continues to serve the healthcare industry with its unique solutions and services.

Revenue: ₹41.05Cr as on March 2025 (Q4 FY25)
Net Profit: ₹8.54Cr as on March 2025 (Q4 FY25)
Chairperson Name: Ashish U Bhuta
OrganisationJenburkt Pharmaceuticals Ltd
IndustryPharmaceuticals
CEOAshish U Bhuta
E-voting on sharesClick here to vote

FAQs

What is Jenburkt Pharmaceuticals Ltd share price today?

Jenburkt Pharmaceuticals Ltd share price today stands at ₹1334.35, Open: ₹1324.1, Previous Close: ₹1319.35, High: ₹1344.9, Low: ₹1302, 52 Week High: ₹1375, 52 Week Low: ₹815.8.

What is today's traded volume of Jenburkt Pharmaceuticals Ltd?

Today's traded volume of Jenburkt Pharmaceuticals Ltd is 1,431.00. Which means that 1,431.00 shares of Jenburkt Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.

What is Jenburkt Pharmaceuticals Ltd's market cap today?

Today's market capitalisation of Jenburkt Pharmaceuticals Ltd is ₹582.27 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Jenburkt Pharmaceuticals Ltd?

Jenburkt Pharmaceuticals Ltd’s 52 week high is ₹1375 and 52 week low is ₹815.8. The current share price of Jenburkt Pharmaceuticals Ltd is ₹1334.35, which is -2.96% down from its 52 week high and 63.56% up from its 52 week low.